|
All TB
|
Non TB
|
p value
|
OR (95% CI)
|
---|
(n = 73)
|
(n = 3014)
|
---|
General data
| | | | |
Age (year)
|
75.15 ± 5.68
|
74.12 ± 5.91
|
0.142
|
1.029 (0.991-1.069)
|
Gender
| | |
<0.001***
|
3.663 (2.119-6.333))
|
Male
|
56 (76.7)
|
1427 (47.3)
|
Female
|
17 (23.3)
|
1587 (52.7)
|
BMI (kg/m2)
|
24.37 ± 3.94
|
25.46 ± 3.87
|
0.017*
|
0.923 (0.864-0.986)
|
Smoking
| | |
<0.001***
|
2.533 (1.576-4.070)
|
Yes
|
31 (42.5)
|
678 (22.5)
|
No
|
41 (56.2)
|
2271 (75.3)
|
Alcohol consumption
| | |
0.001**
|
2.410 (1.425-4.074)
|
Yes
|
20 (27.4)
|
399 (13.2)
|
No
|
53 (72.6)
|
2548 (84.5)
|
TB family history
| | |
<0.001***
|
5.908 (2.437-14.324)
|
Yes
|
6 (8.2)
|
45 (1.5)
|
No
|
67 (91.8)
|
2969 (98.5)
|
DM status
| | | | |
Fasting glucose (mg/dL)
|
147.15 ± 58.64
|
146.15 ± 51.62
|
0.881
|
1.000 (0.996-1.005)
|
HbA1c (%)
|
7.57 ± 1.61
|
7.46 ± 1.43
|
0.541
|
1.050 (0.899-1.226)
|
HDL (mg/dL)
|
41.99 ± 11.79
|
45.44 ± 12.14
|
0.062
|
0.974 (0.948-1.001)
|
LDL (mg/dL)
|
107.64 ± 35.20
|
96.60 ± 29.05
|
0.006*
|
1.012 (1.003-1.020)
|
Triglyceride (mg/dL)
|
138.98 ± 75.20
|
137.13 ± 89.86
|
0.886
|
1.000 (0.997-1.003)
|
Creatinine (mg/dL)
|
1.64 ± 1.80
|
1.49 ± 1.56
|
0.446
|
1.054 (0.921-1.206)
|
ALT (U/L)
|
27.20 ± 17.82
|
29.52 ± 29.39
|
0.615
|
0.996 (0.982-1.011)
|
DM duration (year)
|
10.16 ± 7.37
|
10.63 ± 7.59
|
0.606
|
0.992 (0.960-1.024)
|
Comorbidities
| | | | |
Liver cirrhosis
| | |
0.668
| |
Yes
|
2 (2.7)
|
62 (2.1)
|
1.340 (0.321-5.585)
|
No
|
71 (97.3)
|
2949 (97.8)
|
Hypertension
| | |
<0.001***
|
0.425 (0.266-0.679)
|
Yes
|
32 (43.8)
|
1949 (64.7)
|
No
|
41 (56.2)
|
1062 (35.2)
|
- Data are n (%) unless indicated.
- Abbreviation: BMI: body mass index; DM: diabetes mellitus; HbA1c: glycated hemoglobin; HDL: high-density lipoprotein; LDL: low-density lipoprotein; ALT: alanine aminotransferase.
- All TB group: New TB group + patients with TB history.
- Non TB group: all participants except all TB group.
- *p <0.05, **p < 0.01, ***p < 0.001.